0001209191-15-070557.txt : 20150914 0001209191-15-070557.hdr.sgml : 20150914 20150914172433 ACCESSION NUMBER: 0001209191-15-070557 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150910 FILED AS OF DATE: 20150914 DATE AS OF CHANGE: 20150914 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Insys Therapeutics, Inc. CENTRAL INDEX KEY: 0001516479 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510327886 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10220 SOUTH 51ST STREET STREET 2: SUITE 2 CITY: PHOENIX STATE: AZ ZIP: 85044 BUSINESS PHONE: 602-910-2617 MAIL ADDRESS: STREET 1: 10220 SOUTH 51ST STREET STREET 2: SUITE 2 CITY: PHOENIX STATE: AZ ZIP: 85044 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STANLEY THEODORE H CENTRAL INDEX KEY: 0000938296 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35902 FILM NUMBER: 151106216 MAIL ADDRESS: STREET 1: 4745 WILEY POST WAY SUITE 650 STREET 2: C/O ANESTA CORP CITY: SALT LAKE CITY STATE: UT ZIP: 84116 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-09-10 0 0001516479 Insys Therapeutics, Inc. INSY 0000938296 STANLEY THEODORE H C/O INSYS THERAPEUTICS, INC. 444 SOUTH ELLIS STREET CHANDLER AZ 85224 1 0 0 0 Common Stock 2015-09-10 4 M 0 2000 3.63 A 4000 D Common Stock 2015-09-10 4 S 0 1300 36.00 D 2700 D Common Stock 2015-09-10 4 S 0 700 36.01 D 2000 D Common Stock 2015-09-14 4 M 0 2000 3.63 A 4000 D Common Stock 2015-09-14 4 S 0 2000 38.08 D 2000 D Common Stock 6000 I by non-profit corporation Common Stock 10200 I by limited partnership Stock Option (right to buy) 3.63 2015-09-10 4 M 0 2000 0.00 D 2023-05-13 Common Stock 2000 38000 D Stock Option (right to buy) 3.63 2015-09-14 4 M 0 2000 0.00 D 2023-05-13 Common Stock 2000 36000 D On June 5, 2015, the Issuer effected a 2-for-1 forward stock split pursuant to a stock dividend, resulting in the reporting person's ownership of 1,000 additional shares. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.03 to $37.17 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. On June 5, 2015, the Issuer effected a 2-for-1 forward stock split pursuant to a stock dividend, resulting in the reporting person's ownership of 3,000 additional shares. The Reporting Person disclaims beneficial ownership of the Securities except to the extent of his pecuriniary interest therein. On June 5, 2015, the Issuer effected a 2-for-1 forward stock split pursuant to a stock dividend, resulting in the reporting person's ownership of 5,100 additional shares. The exercise price reflects a 2-for-1 forward stock split effected by the Issuer on June 5, 2015. The option vests in 48 equal monthly installments and will be fully vested and exercisable on May 14, 2017. On June 5, 2015, the Issuer effected a 2-for-1 forward stock split, resulting in the reporting person's ownership of 20,000 additional options. /s/ Darryl S. Baker, Attorney-in-fact 2015-09-14